Cargando…
Urinary gonadotropin fragment (UGF) measurements in the diagnosis and management of ovarian cancer.
UGF is a small peptide present in the urines and tissues of patients with gynecologic cancers. Published research (which, at present, mainly comes from our laboratory) on the general application of UGF as a tumor marker, and on its use in the diagnosis of ovarian cancer, is reviewed, and new studies...
Autores principales: | Cole, L. A., Nam, J. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yale Journal of Biology and Medicine
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2589077/ https://www.ncbi.nlm.nih.gov/pubmed/2596125 |
Ejemplares similares
-
Combination Assay of Urinary β‐Core Fragment of Human Chorionic Gonadotropin with Serum Tumor Markers in Gynecologic Cancers
por: Kinugasa, Masato, et al.
Publicado: (1995) -
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
por: Conforti, Alessandro, et al.
Publicado: (2019) -
Urinary Versus Recombinant Gonadotropins for Ovarian Stimulation in Women Undergoing Treatment with Assisted Reproductive Technology
por: Patki, Ameet, et al.
Publicado: (2018) -
The value of urinary gonadotropins in the diagnosis of central precocious puberty: a meta-analysis
por: Xu, Dan, et al.
Publicado: (2022) -
Clinical Effectiveness of Urinary Human Chorionic Gonadotropin Related Protein (hCGRP) Quantification for Diagnosis of Ectopic Pregnancy
por: Lee, Jae-Kwan, et al.
Publicado: (2005)